AIRGAS MERCHANTS GASES LLC
PharmaAIRGAS MERCHANTS GASES LLC is a pharmaceutical company with 2 FDA-approved products.
AIRGAS MERCHANTS GASES LLC's Key Drugs
AIRGAS MERCHANTS GASES LLC's core commercial portfolio centers on NITROGEN, NF, OXYGEN, USP — its most strategically important drugs approved in the last 15 years.
AIRGAS MERCHANTS GASES LLC's Recent FDA Approvals
New NDA/BLA approvals for AIRGAS MERCHANTS GASES LLC over the last two years — novel drugs only, excluding generics and label supplements.
AIRGAS MERCHANTS GASES LLC's Therapeutic Areas
Disease areas where AIRGAS MERCHANTS GASES LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
AIRGAS MERCHANTS GASES LLC Pipeline Snapshot
Active clinical trials for AIRGAS MERCHANTS GASES LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • NITROGEN, NF leads revenue
- • 2 key drugs tracked
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (2)
Discontinued (0)
Company Info
- First Approval
- 2013-07-16
- Latest
- 2013-07-16
- Applications
- 2